Charges weigh on Lilly earnings
April 18, 2011 at 09:12 AM EDT
The drug maker reports a lower first-quarter profit, due largely to a hefty charge related to its collaboration with Boehringer Ingelheim.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.